Dr Reddy’s Gets FDA Approval to Market Fexofenadine

by Kathy Jones on  April 14, 2011 at 8:12 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration has given its approval for a Abbreviated New Drug Application (ANDA) by Dr Reddy's Laboratories for the production of its Fexofenadine HCl tablets.
 Dr Reddy’s Gets FDA Approval to Market Fexofenadine
Dr Reddy’s Gets FDA Approval to Market Fexofenadine

The tablets are generic version of Sanofi-Aventis' Allegra tablets and will be sold over the counter under store brand labels.

Dr Reddy's revealed that it had got the approval for the drug on April 12, more than three months after the US District Court of New Jersey had given clearance for the company to manufacture the generic version of Allegra-D 24 in US.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...